Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: Effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 5-6, 2000, Pages 313-319

  Rucavado, A ^a   Escalante, T ^a   Franceschi, A ^a   Chaves, F ^a   Leon G ^a   Cury, Y ^a   Ovadia, M ^a   Gutierrez J M ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; CHELATING AGENT; EDETATE CALCIUM DISODIUM; METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BOTHROPS ASPER; CHELATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EDEMA; HUMAN; INHIBITION KINETICS; MALE; MOUSE; MUSCLE INJURY; NONHUMAN; PROTEINASE INHIBITION; RAT; SKIN NECROSIS; SNAKE; SNAKEBITE;

ANIMALIA; BOTHROPS ASPER; CROTALINAE; SERPENTES; VIPER;

EID: 0034438185     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.313     Document Type: Article

References (57)

1. Clinical features of envenoming from snake bites
2. Snake-bites: Appraisal of the global situation
3. Clinical toxicology of snakebite in North America
4. Clinical toxicology of snakebite in Central America
5. Clinical toxicology of snakebite in South America
6. Symptomatology, pathology and treatment of snake bites in South America
7. The global problem of snake bite: Its prevention and treatment
8. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom
9. The sequelae of pit viper poisoning in the United States
10. Accidente ofídico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990)
11. Las serpientes venenosas de Centroamérica y el problema del ofidismo. Primera parte. Aspectos zoológicos, epidemiológicos y biomédicos
12. Snakebite and field biologists in Mexico and Central America: Report on ten cases with recommendations for field management
13. Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco
14. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper
15. Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper (terciopelo)
16. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: An intravital and electron microscopic study
17. Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice
18. Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper
19. 2 myotoxins from Bothrops snake venoms
20. Bothrops asper hemorrhagic proteinases BaH1 and BaP1
21. Pathology of rattlesnake envenomation
22. Pathological changes induced by BAH1, a hemorrhagic metalloproteinase isolated from Bothrops asper (terciopelo) snake venom, on mouse capillary blood vessels
23. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (terciopelo) snake venom
24. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo)
25. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom: Pathogenesis of hemorrhage induced by three purified toxins
26. Pathogenesis of hemorrhage induced by bilitoxin, a hemorrhagic toxin isolated from the venom of the common cantil (Agkistrodon bilineatus bilineatus)
27. Skeletal muscle necrosis and regeneration after injection of BAH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (terciopelo)
28. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Metturn) and topologies and should be grouped into a common family, the 'metzincins'
29. Hemorrhagic metalloproteinases from snake venoms
30. Heavy metals and heavy metal antagonists
31. Mobilization of lead by calcium versenate and dimercaptosuccinate in the rat
32. Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture
33. 2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: Application in horse immunization for antivenom production
34. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper
35. A method for measurement of analgesic activity on inflammed tissue
36. A new ultrasensitive method for the determination of proteolytic activity
37. Standardization of assays for testing the neutralizing ability of antivenoms
38. Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America
39. Studies on the quantitative method for the determination of hemorrhagic activity of Habu snake venom
40. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom
41. A new method for quantitating hemorrhage induced by rattlesnake venoms: Ability of polyvalent antivenom to neutralize hemorrhagic activity
42. Development of simple standard assay procedures for the characterization of snake venoms
43. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model
44. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper
45. A new muscle-damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)
46. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil
47. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom
48. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom
49. Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper
50. The chemical modification of necrogenic and proteolytic activities of venom and the use of EDTA to produce Agkistrodon piscivorous, a venom toxoid
51. Effect of diethylenetria-minepentaacetic acid and procaine on hemorrhage induced by rattlesnake venom
52. Recurrent and persistent coagulopathy following pit viper envenomation
53. Matrix metalloproteinase inhibitors in arthritis
54. Chelation therapy of atherosclerosis
55. Matrix metalloproteinase inhibitors
56. Clinical studies with matrix metalloproteinase inhibitors